Investment
Features
FeesSafety
Academy
More
Pluang+

DeFiChain (DFI) surges 31.74% in 15 minutes despite low trading volume

Market News
19 Oct 2026
Tokenpost
View Source
Bullish
DeFiChain (DFI) surges 31.74% in 15 minutes despite low trading volume

DeFiChain (DFI) experienced a sharp price increase of 31.74% within 15 minutes, rising from $0.00041973 to $0.000553. This jump occurred amid very low trading volume of just $156.26 over 24 hours, indicating limited market activity. Despite the brief rebound, DFI had been in a longer downtrend with a nearly 9.92% decline over the previous day. The token's market capitalization stood at approximately $509,871, and the price move captured only part of the day's overall range, suggesting volatility amid thin trading.

DeFiChain (DFI) saw a sharp 31.74% price rise in 15 minutes to $0.000553. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 20, 2026 07:21 WIB: 32 of 50 major cryptocurrencies rose today. Notable movers include BAL at Rp16.297 (+11.14%), BAT at Rp3.477 (+10.29%), and EOS at Rp12.649 (+8.13%).

More News

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...

Company Fundamentals
Bullish
2 hours ago
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...

Market News
Bullish
2 hours ago
Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...

Company Fundamentals
Bullish
3 hours ago
XRP market value drops $61B in a year as Evernorth launches XRP treasury company on Nasdaq

XRP market value drops $61B in a year as Evernorth launches XRP treasury company on Nasdaq

XRP's circulating market value fell by $61.14 billion, or 42.64%, from $143.38 billion on Oct. 19, 2025, to $82.24 billion a year later, driven by a price drop from $2.39 to $1.30 despite a slight increase in circulating supply. Meanwhile, Evernorth ...

Market News
Neutral
4 hours ago
Remitly's revenue grows 20% with strong product expansion, yet valuation undervalues its potential.

Remitly's revenue grows 20% with strong product expansion, yet valuation undervalues its potential.

Remitly reported a 20% year-over-year revenue increase to $495 million, supported by 10.2 million active customers and a 197% rise in Free Cash Flow. The company is expanding its product offerings with the Remitly Card and Pay Later services, which, ...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App